GlassScriptPhysician profile
Kristopher M Oswalt
NPI 1205954302
$889.85
in general payments reported to CMS, 2019-2025
21 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $86.45 · 2022: $28.15 · 2023: $124 · 2024: $116 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $125.02 | 2019-2025 | Suflave, Sutab |
| Takeda Pharmaceuticals U.S.A., INC. | $95.51 | 2019-2024 | Gattex |
| Melinta Therapeutics, LLC | $92.81 | 2019 | |
| Smith+Nephew, INC. | $79.55 | 2019-2023 | Pico |
| Mallinckrodt Enterprises LLC | $66.51 | 2019 | |
| Ferring Pharmaceuticals INC. | $55.40 | 2023 | Rebyota, Clenpiq |
| Vertex Pharmaceuticals Incorporated | $53.14 | 2024-2025 | |
| Heron Therapeutics, INC. | $52.89 | 2022-2025 | Zynrelef |
| Tela Bio, INC. | $33.58 | 2024 | Ovitex 2s |
| Abbvie INC. | $31.23 | 2025 | |
| Allergan, INC. | $30.00 | 2020 | |
| Olympus America INC. | $24.82 | 2025 | Olympus, Visera Elite Video System Center, 4k Camera Head |
| Astrazeneca Pharmaceuticals LP | $20.33 | 2019 | |
| Concordia Pharmaceuticals INC. | $19.94 | 2019 | |
| Portola Pharmaceuticals, LLC | $19.48 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.09 | 2020 | |
| Ethicon US, LLC | $16.52 | 2019 | |
| Organogenesis INC. | $14.76 | 2022 | |
| Shire North American Group INC | $13.71 | 2019 | |
| Davol INC. | $13.70 | 2025 | Phasix Mesh |
| Osiris Therapeutics INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristopher Oswalt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.